GSK PLC Director/PDMR Shareholding
17 October 2024 - 2:09AM
RNS Regulatory News
RNS Number : 4796I
GSK PLC
16 October 2024
GSK plc
(the 'Company')
Transaction notification
|
1.
|
Details of
PDMR/person closely associated with them ('PCA')
|
|
a)
|
Name
|
David Redfern
|
|
b)
|
Position/status
|
President Corporate Development
|
|
c)
|
Initial notification/
amendment
|
Initial notification
|
|
2.
|
Details of the
issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
|
|
a)
|
Name
|
GSK plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the
transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
|
a)
|
Description of the financial
instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary
Shares')
ISIN: GB00BN7SWP63
|
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the
re-investment of dividends paid to shareholders on 10 October 2024,
on Ordinary Shares held within an ISA
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
|
£ 14.9650
|
20
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
N/A (single transaction)
|
|
Aggregated volume Price
|
|
|
e)
|
Date of the transaction
|
2024-10-11
|
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|
1.
|
Details of
PDMR/person closely associated with them ('PCA')
|
|
a)
|
Name
|
Victoria Whyte
|
|
b)
|
Position/status
|
Company Secretary
|
|
c)
|
Initial notification/
amendment
|
Initial notification
|
|
2.
|
Details of the
issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
|
|
a)
|
Name
|
GSK plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the
transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transaction(s) has been
conducted
|
|
a)
|
Description of the financial
instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary
Shares')
ISIN: GB00BN7SWP63
|
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the
re-investment of dividends paid to shareholders on 10 October 2024,
on Ordinary Shares held within an ISA
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
|
£ 14.9650
|
17
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
N/A (single transaction)
|
|
Aggregated volume Price
|
|
|
e)
|
Date of the transaction
|
2024-10-11
|
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHFFWFIMELSESS
Gsk (LSE:GSK)
Historical Stock Chart
From Nov 2024 to Dec 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Dec 2023 to Dec 2024
